CHRM4 and neoplasm: When mice were subcutaneously injected with PC3 cells with CHRM4-KD, we observed that both tumor size and weight significantly decreased in CHRM4-KD cell-bearing mice relative to control cell-bearing mice (Fig. 3I–K).